{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Coenzyme Q10", "Contrast induced-acute kidney injury", "Primary percutaneous coronary intervention", "ST-segment elevation myocardial infarction"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37524929", "DateCompleted": {"Year": "2023", "Month": "09", "Day": "18"}, "DateRevised": {"Year": "2023", "Month": "09", "Day": "22"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "08", "Day": "01"}], "Language": ["eng"], "ELocationID": ["10.1007/s00228-023-03546-9"], "Journal": {"ISSN": "1432-1041", "JournalIssue": {"Volume": "79", "Issue": "10", "PubDate": {"Year": "2023", "Month": "Oct"}}, "Title": "European journal of clinical pharmacology", "ISOAbbreviation": "Eur J Clin Pharmacol"}, "ArticleTitle": "Prevention of contrast induced-acute kidney injury using coenzyme Q10 in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.", "Pagination": {"StartPage": "1341", "EndPage": "1356", "MedlinePgn": "1341-1356"}, "Abstract": {"AbstractText": ["We assessed the potential effect of CoQ10 administration for the prevention of contrast induced-acute kidney injury (CI-AKI) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI).", "One hundred fifty STEMI patients who were candidates for primary PCI, along with intravenous saline hydration, randomly received a placebo or CoQ10. CoQ10 was administrated orally, 400 mg before the procedure and 200 mg twice daily after the procedure for three consecutive days. Serum creatinine concentration and corresponding creatinine clearance (estimated by the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation) were measured at baseline and 24, 48, and 72 h after primary PCI. Furthermore, the serum level of superoxide dismutase (SOD), total antioxidant capacity (TAC), and malondialdehyde (MDA) was measured before and 72 h after primary PCI.", "The mean serum creatinine concentration before contrast administration was similar in the two groups (0.98\u2009\u00b1\u20090.08 versus 0.99\u2009\u00b1\u20090.09\u00a0mg/dL). While in both study groups, compared to baseline, the mean serum creatinine concentration increased at 48 and 72 h after contrast exposure, the CoQ10 group showed a lower serum creatinine concentration than the placebo group (P-value\u2009=\u20090.017 and 0.004, respectively). However, comparing the mean values of creatinine clearance between the groups at the study time points did not demonstrate a statistically significant difference. CI-AKI, defined as a\u2009>\u200925% or 0.5 mg/dL increase in baseline serum creatinine concentration, occurred in 8.00% of the cases in the CoQ10 group versus 20.00% in the placebo group (P-value\u2009=\u20090.034). Furthermore, at 72 h, the CoQ10-treated group exhibited higher serum levels of SOD and TAC and a lower MDA level than the placebo-treated group.", "Our research's findings proposed CoQ10 supplementation as an adjuvant to saline hydration as a preventive approach against CI-AKI.", "The trial was registered at Iranian Registry of Clinical Trials ( https://www.irct.ir/trial/60435 , identifier code: IRCT20120215009014N414). Registration date: 2021-12-29."], "CopyrightInformation": "\u00a9 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran."}], "LastName": "Ahmadimoghaddam", "ForeName": "Davoud", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran."}], "LastName": "Talebi", "ForeName": "Seyed Saman", "Initials": "SS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, School of Pharmacy, Medicinal Plants and Natural Products Research Center, Hamadan University of Medical Sciences, Shahid Fahmideh Ave, Hamadan, 6517838678, Iran."}], "LastName": "Rahmani", "ForeName": "Ayesheh", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Faculty, Hamadan University of Medical Science, Hamadan, Iran."}], "LastName": "Zamanirafe", "ForeName": "Maryam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cardiology, School of Medicine, Clinical Research Development Unit of Farshchian Hospital, Hamadan University of Medical Sciences, Hamadan, Iran."}], "LastName": "Parvaneh", "ForeName": "Erfan", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran."}], "LastName": "Ranjbar", "ForeName": "Akram", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran."}], "LastName": "Poorolajal", "ForeName": "Jalal", "Initials": "J"}, {"Identifier": ["0000-0003-4119-1600"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, School of Pharmacy, Medicinal Plants and Natural Products Research Center, Hamadan University of Medical Sciences, Shahid Fahmideh Ave, Hamadan, 6517838678, Iran. m_mehrpooya2003@yahoo.com."}], "LastName": "Mehrpooya", "ForeName": "Maryam", "Initials": "M"}], "GrantList": [{"GrantID": "140011199720", "Agency": "Vice-chancellor for research and technology, Hamadan University of Medical Sciences", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Eur J Clin Pharmacol", "NlmUniqueID": "1256165", "ISSNLinking": "0031-6970"}, "ChemicalList": [{"RegistryNumber": "EJ27X76M46", "NameOfSubstance": "coenzyme Q10"}, {"RegistryNumber": "AYI8EX34EU", "NameOfSubstance": "Creatinine"}, {"RegistryNumber": "0", "NameOfSubstance": "Contrast Media"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "surgery"], "DescriptorName": "ST Elevation Myocardial Infarction"}, {"QualifierName": ["adverse effects", "methods"], "DescriptorName": "Percutaneous Coronary Intervention"}, {"QualifierName": [], "DescriptorName": "Creatinine"}, {"QualifierName": [], "DescriptorName": "Contrast Media"}, {"QualifierName": [], "DescriptorName": "Iran"}, {"QualifierName": ["chemically induced", "prevention & control"], "DescriptorName": "Acute Kidney Injury"}, {"QualifierName": [], "DescriptorName": "Renal Insufficiency, Chronic"}, {"QualifierName": [], "DescriptorName": "Risk Factors"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Nash K, Hafeez A, Hou S (2002) Hospital-acquired renal insufficiency. Am J Kidney Dis 39(5):930\u2013936", "ArticleIdList": ["11979336", "10.1053/ajkd.2002.32766"]}, {"Citation": "Stacul F, van der Molen AJ, Reimer P, Webb JA, Thomsen HS, Morcos SK, Alm\u00e9n T, Aspelin P, Bellin M-F, Clement O (2011) Contrast induced nephropathy: updated ESUR contrast media safety committee guidelines. Eur Radiol 21(12):2527\u20132541", "ArticleIdList": ["21866433", "10.1007/s00330-011-2225-0"]}, {"Citation": "Mohammed NM, Mahfouz A, Achkar K, Rafie IM, Hajar R (2013) Contrast-induced nephropathy. Heart views: the official journal of the Gulf Heart Association 14(3):106", "ArticleIdList": ["24696755", "10.4103/1995-705X.125926"]}, {"Citation": "Mehran R, Nikolsky E (2006) Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int 69:S11\u2013S15", "ArticleIdList": ["10.1038/sj.ki.5000368"]}, {"Citation": "Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44(7):1393\u20131399", "ArticleIdList": ["15464318"]}, {"Citation": "Sgura FA, Bertelli L, Monopoli D, Leuzzi C, Guerri E, Spart\u00e0 I, Politi L, Aprile A, Amato A, Rossi R: Mehran contrast-induced nephropathy risk score predicts short-and long-term clinical outcomes in patients with ST-elevation\u2013myocardial infarction. Circulation: Cardiovascular Interventions 2010, 3(5):491\u2013498."}, {"Citation": "Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I, Grazi M, Veglia F, Bartorelli AL (2004) Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 44(9):1780\u20131785", "ArticleIdList": ["15519007", "10.1016/j.jacc.2004.07.043"]}, {"Citation": "James MT, Ghali WA, Tonelli M, Faris P, Knudtson ML, Pannu N, Klarenbach SW, Manns BJ, Hemmelgarn BR (2010) Acute kidney injury following coronary angiography is associated with a long-term decline in kidney function. Kidney Int 78(8):803\u2013809", "ArticleIdList": ["20686453", "10.1038/ki.2010.258"]}, {"Citation": "Walsh CR, O\u2019Donnell CJ, Camargo CA Jr, Giugliano RP, Lloyd-Jones DM (2002) Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction. Am Heart J 144(6):1003\u20131011", "ArticleIdList": ["12486424", "10.1067/mhj.2002.125504"]}, {"Citation": "Silvain J, Nguyen LS, Spagnoli V, Kerneis M, Guedeney P, Vignolles N, Cosker K, Barthelemy O, Le Feuvre C, Helft G (2018) Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart 104(9):767\u2013772", "ArticleIdList": ["29092921", "10.1136/heartjnl-2017-311975"]}, {"Citation": "Solomon R (2008) Contrast-induced acute kidney injury: is there a risk after intravenous contrast? Clinical journal of the American Society of Nephrology: CJASN 3(5):1242", "ArticleIdList": ["18701610", "4571161", "10.2215/CJN.03470708"]}, {"Citation": "Dong M, Jiao Z, Liu T, Guo F, Li G (2012) Effect of administration route on the renal safety of contrast agents: a meta-analysis of randomized controlled trials. J Nephrol 25(3):290", "ArticleIdList": ["22252847", "10.5301/jn.5000067"]}, {"Citation": "van der Molen AJ, Reimer P, Dekkers IA, Bongartz G, Bellin M-F, Bertolotto M, Clement O, Heinz-Peer G, Stacul F, Webb JA (2018) Post-contrast acute kidney injury\u2013part 1: definition, clinical features, incidence, role of contrast medium and risk factors: recommendations for updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol 28:2845\u20132855", "ArticleIdList": ["29426991", "5986826", "10.1007/s00330-017-5246-5"]}, {"Citation": "Nyman U, Alm\u00e9n T, Jacobsson B, Aspelin P (2012) Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections? Eur Radiol 22:1366\u20131371", "ArticleIdList": ["22307815", "10.1007/s00330-011-2371-4"]}, {"Citation": "Liu Y, Hong D, Wang AY, Guo R, Smyth B, Liu J, Sun G, Chen S, Tan N, Jardine M (2019) Effects of intravenous hydration on risk of contrast induced nephropathy and in-hospital mortality in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials. BMC Cardiovasc Disord 19(1):1\u20139", "ArticleIdList": ["10.1186/s12872-019-1054-y"]}, {"Citation": "Nikolsky E, Mehran R (2003) Understanding the consequences of contrast-induced nephropathy. Rev Cardiovasc Med 4(S5):10\u201318"}, {"Citation": "Loomba RS, Shah PH, Aggarwal S, Arora RR (2016) Role of N-acetylcysteine to prevent contrast-induced nephropathy: a meta-analysis. Am J Ther 23(1):e172\u2013e183", "ArticleIdList": ["23982694", "10.1097/MJT.0b013e31829dbc1c"]}, {"Citation": "Weisbord SD, Gallagher M, Jneid H, Garcia S, Cass A, Thwin S-S, Conner TA, Chertow GM, Bhatt DL, Shunk K (2018) Outcomes after angiography with sodium bicarbonate and acetylcysteine. N Engl J Med 378(7):603\u2013614", "ArticleIdList": ["29130810", "10.1056/NEJMoa1710933"]}, {"Citation": "Zapata-Chica CA, Bello Marquez D, Serna-Higuita LM, Nieto-R\u00edos JF, Casas-Arroyave FD, Donado-G\u00f3mez JH (2015) Sodium bicarbonate versus isotonic saline solution to prevent contrast-induced nephropathy: a systematic review and meta-analysis. Colomb Med 46(3):90\u2013103", "ArticleIdList": ["10.25100/cm.v46i3.1925"]}, {"Citation": "Investigators* A: Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). Circulation 2011, 124(11):1250\u20131259."}, {"Citation": "Heyman SN, Rosen S, Khamaisi M, Id\u00e9e J-M, Rosenberger C (2010) Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy. Invest Radiol 45(4):188\u2013195", "ArticleIdList": ["20195159", "10.1097/RLI.0b013e3181d2eed8"]}, {"Citation": "Hizoh I, Haller C (2002) Radiocontrast-induced renal tubular cell apoptosis: hypertonic versus oxidative stress. Invest Radiol 37(8):428\u2013434", "ArticleIdList": ["12138358", "10.1097/00004424-200208000-00003"]}, {"Citation": "Bakris GL, Lass N, Gaber AO, Jones JD, Burnett J Jr (1990) Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. American Journal of Physiology-Renal Physiology 258(1):F115\u2013F120", "ArticleIdList": ["10.1152/ajprenal.1990.258.1.F115"]}, {"Citation": "Caiazza A, Russo L, Sabbatini M, Russo D: Hemodynamic and tubular changes induced by contrast media. BioMed research international 2014, 2014."}, {"Citation": "Cheng W, Zhao F, Tang C-Y, Li X-W, Luo M, Duan S-B (2018) Comparison of iohexol and iodixanol induced nephrotoxicity, mitochondrial damage and mitophagy in a new contrast-induced acute kidney injury rat model. Arch Toxicol 92(7):2245\u20132257", "ArticleIdList": ["29860548", "10.1007/s00204-018-2225-9"]}, {"Citation": "Jorgensen AL (2013) Contrast-induced nephropathy: pathophysiology and preventive strategies. Crit Care Nurse 33(1):37\u201346", "ArticleIdList": ["23377156", "10.4037/ccn2013680"]}, {"Citation": "Kusirisin P, Chattipakorn SC, Chattipakorn N (2020) Contrast-induced nephropathy and oxidative stress: mechanistic insights for better interventional approaches. J Transl Med 18(1):1\u201335", "ArticleIdList": ["10.1186/s12967-020-02574-8"]}, {"Citation": "Littarru GP, Lambrechts P (2011) Coenzyme Q 10: multiple benefits in one ingredient. Ol\u00e9agineux, Corps gras, Lipides 18(2):76\u201382", "ArticleIdList": ["10.1051/ocl.2011.0374"]}, {"Citation": "Sangsefidi ZS, Yaghoubi F, Hajiahmadi S, Hosseinzadeh M (2020) The effect of coenzyme Q10 supplementation on oxidative stress: a systematic review and meta-analysis of randomized controlled clinical trials. Food Sci Nutr 8(4):1766\u20131776", "ArticleIdList": ["32328242", "7174219", "10.1002/fsn3.1492"]}, {"Citation": "Abiri B, Vafa M (2021) Impact of coenzyme Q10 on inflammatory biomarkers and its role in future therapeutic strategies. Clinical Nutrition ESPEN 43:25\u201330", "ArticleIdList": ["34024523", "10.1016/j.clnesp.2021.04.005"]}, {"Citation": "Jahangard L, Yasrebifar F, Haghighi M, Ranjbar A, Mehrpooya M (2019) Influence of adjuvant coenzyme Q10 on inflammatory and oxidative stress biomarkers in patients with bipolar disorders during the depressive episode. Mol Biol Rep 46(5):5333\u20135343", "ArticleIdList": ["31346916", "10.1007/s11033-019-04989-z"]}, {"Citation": "Tiano L, Belardinelli R, Carnevali P, Principi F, Seddaiu G, Littarru GP (2007) Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study. Eur Heart J 28(18):2249\u20132255", "ArticleIdList": ["17644511", "10.1093/eurheartj/ehm267"]}, {"Citation": "Bank G, Kagan D, Madhavi D (2011) Coenzyme Q10: clinical update and bioavailability. Journal of Evidence-Based Complementary & Alternative Medicine 16(2):129\u2013137", "ArticleIdList": ["10.1177/2156587211399438"]}, {"Citation": "Kalayci M, Unal MM, Gul S, Acikgoz S, Kandemir N, Hanci V, Edebali N, Acikgoz B (2011) Effect of coenzyme Q10 on ischemia and neuronal damage in an experimental traumatic brain-injury model in rats. BMC Neurosci 12(1):1\u20137", "ArticleIdList": ["10.1186/1471-2202-12-75"]}, {"Citation": "Chen Q, Qi S, Hocum-Stone L, Lesnefsky E, Kelly RF, McFalls EO (2021) Preventing myocardial injury following non-cardiac surgery: a potential role for preoperative antioxidant therapy with ubiquinone. Antioxidants 10(2):276", "ArticleIdList": ["33579045", "7916807", "10.3390/antiox10020276"]}, {"Citation": "Ali FE, Ahmed SF, Eltrawy AH, Yousef RS, Ali HS, Mahmoud AR, Abd-Elhamid TH (2021) Pretreatment with coenzyme Q10 combined with aescin protects against sepsis-induced acute lung injury. Cells Tissues Organs 210(3):195\u2013217", "ArticleIdList": ["34280918", "10.1159/000516192"]}, {"Citation": "Li Q-w, Yang Q, Liu H-Y, Wu Y-l, Hao Y-H, Zhang X-Q: Protective role of Coenzyme Q10 in acute sepsis-induced liver injury in BALB/c Mice. BioMed Research International 2020, 2020."}, {"Citation": "Zhao S, Wu W, Liao J, Zhang X, Shen M, Li X, Lin Q, Cao C (2022) Molecular mechanisms underlying the renal protective effects of coenzyme Q10 in acute kidney injury. Cell Mol Biol Lett 27(1):1\u201319", "ArticleIdList": ["10.1186/s11658-022-00361-5"]}, {"Citation": "Chen F, Liu F, Lu J, Yang X, Xiao B, Jin Y, Zhang J (2018) Coenzyme Q10 combined with trimetazidine in the prevention of contrast-induced nephropathy in patients with coronary heart disease complicated with renal dysfunction undergoing elective cardiac catheterization: a randomized control study and in vivo study. Eur J Med Res 23(1):1\u201310", "ArticleIdList": ["10.1186/s40001-018-0320-2"]}, {"Citation": "Alshogran OY, Nusair SD, El-Elimat T, Alzoubi KH, Obeidat A, Sweidan M (2021) Evaluation of coenzyme Q10 combined with or without N-acetyl cysteine or atorvastatin for preventing contrast-induced kidney injury in diabetic rats. Naunyn Schmiedebergs Arch Pharmacol 394(7):1403\u20131410", "ArticleIdList": ["33630121", "10.1007/s00210-021-02070-w"]}, {"Citation": "Couto SMF, da Fonseca CD, Watanabe M (2021) de F\u00e1tima Fernandes Vattimo M: Protection of coenzyme Q10 against contrast-induced acute kidney injury in male diabetic rats. Diabetol Metab Syndr 13(1):1\u201310", "ArticleIdList": ["10.1186/s13098-021-00689-6"]}, {"Citation": "Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio AL, Crea F, Goudevenos JA, Halvorsen S (2018) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39(2):119\u2013177", "ArticleIdList": ["28886621", "10.1093/eurheartj/ehx393"]}, {"Citation": "Chesebro J, Knatterud G, Roberts R, Borer J, Cohen L, Dalen J, Dodge H, Francis C, Hillis D, Ludbrook P (1987) Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge Circulation 76(1):142\u2013154", "ArticleIdList": ["3109764"]}, {"Citation": "Langsjoen PH, Langsjoen AM (2014) Comparison study of plasma coenzyme Q10 levels in healthy subjects supplemented with ubiquinol versus ubiquinone. Clinical pharmacology in drug development 3(1):13\u201317", "ArticleIdList": ["27128225", "10.1002/cpdd.73"]}, {"Citation": "Langsjoen PH, Langsjoen AM (2008) Supplemental ubiquinol in patients with advanced congestive heart failure. BioFactors 32(1\u20134):119\u2013128", "ArticleIdList": ["19096107", "10.1002/biof.5520320114"]}, {"Citation": "Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, Crews DC, Doria A, Estrella MM, Froissart M (2021) New creatinine-and cystatin C\u2013based equations to estimate GFR without race. N Engl J Med 385(19):1737\u20131749", "ArticleIdList": ["34554658", "8822996", "10.1056/NEJMoa2102953"]}, {"Citation": "Levin A, Stevens PE (2014) Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int 85(1):49\u201361", "ArticleIdList": ["24284513", "10.1038/ki.2013.444"]}, {"Citation": "Matzke GR, Aronoff GR, Atkinson AJ Jr, Bennett WM, Decker BS, Eckardt K-U, Golper T, Grabe DW, Kasiske B, Keller F (2011) Drug dosing consideration in patients with acute and chronic kidney disease\u2014a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 80(11):1122\u20131137", "ArticleIdList": ["21918498", "10.1038/ki.2011.322"]}, {"Citation": "\u014cyanagui Y (1984) Reevaluation of assay methods and establishment of kit for superoxide dismutase activity. Anal Biochem 142(2):290\u2013296", "ArticleIdList": ["6099057", "10.1016/0003-2697(84)90467-6"]}, {"Citation": "Benzie IF, Szeto Y (1999) Total antioxidant capacity of teas by the ferric reducing/antioxidant power assay. J Agric Food Chem 47(2):633\u2013636", "ArticleIdList": ["10563944", "10.1021/jf9807768"]}, {"Citation": "Botsoglou NA, Fletouris DJ, Papageorgiou GE, Vassilopoulos VN, Mantis AJ, Trakatellis AG (1994) Rapid, sensitive, and specific thiobarbituric acid method for measuring lipid peroxidation in animal tissue, food, and feedstuff samples. J Agric Food Chem 42(9):1931\u20131937", "ArticleIdList": ["10.1021/jf00045a019"]}, {"Citation": "Thomsen HS (2003) Guidelines for contrast media from the European Society of Urogenital Radiology. Am J Roentgenol 181(6):1463\u20131471", "ArticleIdList": ["10.2214/ajr.181.6.1811463"]}, {"Citation": "Li W, Fu X, Wang Y, Li X, Yang Z, Wang X, Geng W, Gu X, Hao G, Jiang Y (2012) Beneficial effects of high-dose atorvastatin pretreatment on renal function in patients with acute ST-segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention. Cardiology 122(3):195\u2013202", "ArticleIdList": ["22854323", "10.1159/000339472"]}, {"Citation": "Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME, Kosiborod M, Amin AP, Messenger JC, Rumsfeld JS: Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. JACC: Cardiovascular Interventions 2014, 7(1):1\u20139."}, {"Citation": "Narula A, Mehran R, Weisz G, Dangas GD, Yu J, G\u00e9n\u00e9reux P, Nikolsky E, Brener SJ, Witzenbichler B, Guagliumi G (2014) Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy. Eur Heart J 35(23):1533\u20131540", "ArticleIdList": ["24603308", "10.1093/eurheartj/ehu063"]}, {"Citation": "Chong E, Poh KK, Liang S, Soon CY (2010) TAN HC: Comparison of risks and clinical predictors of contrast-induced nephropathy in patients undergoing emergency versus nonemergency percutaneous coronary interventions. J Interv Cardiol 23(5):451\u2013459", "ArticleIdList": ["20796168", "10.1111/j.1540-8183.2010.00581.x"]}, {"Citation": "Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, Miller WL, Murphy JG, Kopecky SL, Jaffe AS (2002) Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 137(7):563\u2013570", "ArticleIdList": ["12353943", "10.7326/0003-4819-137-7-200210010-00007"]}, {"Citation": "Han B, Li Y, Dong Z, Wan Q, Shen H, Li J, Wei M, Shen C (2018) Diastolic dysfunction predicts the risk of contrast-induced nephropathy and outcome post-emergency percutaneous coronary intervention in AMI patients with preserved ejection fraction. Heart Vessels 33(10):1149\u20131158", "ArticleIdList": ["29704102", "10.1007/s00380-018-1165-x"]}, {"Citation": "Tumlin J, Stacul F, Adam A, Becker CR, Davidson C, Lameire N, McCullough PA, Panel CCW (2006) Pathophysiology of contrast-induced nephropathy. Am J Cardiol 98(6):14\u201320", "ArticleIdList": ["10.1016/j.amjcard.2006.01.020"]}, {"Citation": "Mehran R, Dangas GD, Weisbord SD (2019) Contrast-associated acute kidney injury. N Engl J Med 380(22):2146\u20132155", "ArticleIdList": ["31141635", "10.1056/NEJMra1805256"]}, {"Citation": "Xing Y (2015) Wei R-b, Tang L, Yang Y, Zheng X-y, Wang Z-c, Gao Y-w: Protective effect of salidroside on contrast-induced nephropathy in comparison with N-acetylcysteine and its underlying mechanism. Chin J Integr Med 21:266\u2013273", "ArticleIdList": ["25877653", "10.1007/s11655-015-2137-y"]}, {"Citation": "Kongkham S, Sriwong S, Tasanarong A (2013) Protective effect of alpha tocopherol on contrast-induced nephropathy in rats. Nefrolog\u00eda (English Edition) 33(1):116\u2013123"}, {"Citation": "\u00c7etin M, Devrim E, Serin Kilicoglu S, Erg\u00fcder IB, Namuslu M, \u00c7etin R, Durak I (2008) Ionic high-osmolar contrast medium causes oxidant stress in kidney tissue: partial protective role of ascorbic acid. Ren Fail 30(5):567\u2013572", "ArticleIdList": ["18569939", "10.1080/08860220802064739"]}, {"Citation": "Kunak CS, Ugan RA, Cadirci E, Karakus E, Polat B, Un H, Halici Z, Saritemur M, Atmaca HT, Karaman A (2016) Nephroprotective potential of carnitine against glycerol and contrast-induced kidney injury in rats through modulation of oxidative stress, proinflammatory cytokines, and apoptosis. Br J Radiol 89(1058):20140724", "ArticleIdList": ["26562095", "10.1259/bjr.20140724"]}, {"Citation": "Onk D, Onk OA, Turkmen K, Erol HS, Ayazoglu TA, Keles ON, Halici M, Topal E: Melatonin attenuates contrast-induced nephropathy in diabetic rats: the role of interleukin-33 and oxidative stress. Mediators of inflammation 2016, 2016."}, {"Citation": "Drager LF, Andrade L (2004) Barros de Toledo JF, Laurindo FR, Machado C\u00e9sar LA, Seguro AC: Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury. Nephrol Dial Transplant 19(7):1803\u20131807", "ArticleIdList": ["15128882", "10.1093/ndt/gfh261"]}, {"Citation": "Spargias K, Alexopoulos E, Kyrzopoulos S, Iacovis P, Greenwood DC, Manginas A, Voudris V, Pavlides G, Buller CE, Kremastinos D (2004) Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 110(18):2837\u20132842", "ArticleIdList": ["15492300", "10.1161/01.CIR.0000146396.19081.73"]}, {"Citation": "Gutierrez-Mariscal FM, Yubero-Serrano EM, Villalba JM, Lopez-Miranda J (2019) Coenzyme Q10: From bench to clinic in aging diseases, a translational review. Crit Rev Food Sci Nutr 59(14):2240\u20132257", "ArticleIdList": ["29451807", "10.1080/10408398.2018.1442316"]}, {"Citation": "ML JR, Jim\u00e9nez G: Encephalopathy, kidney failure and retinopathy. CoQ10 deficiency due to COQ8B mutation. In: Anales de Pediatria: 2021; 2021: 415\u2013417."}, {"Citation": "Lippa S, Colacicco L, Calla C, Sagliaschi G, Angelitti A (1994) Coenzyme Q10 levels, plasma lipids and peroxidation extent in renal failure and in hemodialytic patients. Mol Aspects Med 15:s213\u2013s219", "ArticleIdList": ["7752833", "10.1016/0098-2997(94)90031-0"]}, {"Citation": "Mantle D, Hargreaves I (2019) Coenzyme Q10 and degenerative disorders affecting longevity: an overview. Antioxidants 8(2):44", "ArticleIdList": ["30781472", "6406788", "10.3390/antiox8020044"]}, {"Citation": "Schijvens AM, van de Kar NC, Bootsma-Robroeks CM, Cornelissen EA, van den Heuvel LP, Schreuder MF (2020) Mitochondrial disease and the kidney with a special focus on CoQ10 deficiency. Kidney international reports 5(12):2146\u20132159", "ArticleIdList": ["33305107", "7710892", "10.1016/j.ekir.2020.09.044"]}, {"Citation": "Bakhshayeshkaram M, Lankarani KB, Mirhosseini N, Tabrizi R, Akbari M, Dabbaghmanesh MH, Asemi Z (2018) The effects of coenzyme Q10 supplementation on metabolic profiles of patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials. Curr Pharm Des 24(31):3710\u20133723", "ArticleIdList": ["30417782", "10.2174/1381612824666181112112857"]}, {"Citation": "Littarru GP, Tiano L (2007) Bioenergetic and antioxidant properties of coenzyme Q10: recent developments. Mol Biotechnol 37(1):31\u201337", "ArticleIdList": ["17914161", "10.1007/s12033-007-0052-y"]}, {"Citation": "Kagan V, Serbinova E, Packer L (1990) Antioxidant effects of ubiquinones in microsomes and mitochondria are mediated by tocopherol recycling. Biochem Biophys Res Commun 169(3):851\u2013857", "ArticleIdList": ["2114108", "10.1016/0006-291X(90)91971-T"]}, {"Citation": "Mancini A, Milardi D, Meucci E, Bianchi A, Pantano AL, Giacchi E, Littarru G, De Marinis L, Pontecorvi A: Coenzyme Q10 effects on non-enzymatic total antioxidant capacity in seminal plasma of varicocele patients. In: International Congress Series: 2004: Elsevier; 2004: 215\u2013218."}, {"Citation": "Noh Y, Kim K, Shim M, Choi S, Choi S, Ellisman M, Weinreb R, Perkins G, Ju W (2013) Inhibition of oxidative stress by coenzyme Q10 increases mitochondrial mass and improves bioenergetic function in optic nerve head astrocytes. Cell Death Dis 4(10):e820\u2013e820", "ArticleIdList": ["24091663", "3824651", "10.1038/cddis.2013.341"]}, {"Citation": "Li L, Du J, Lian Y, Zhang Y, Li X, Liu Y, Zou L, Wu T (2016) Protective effects of coenzyme Q10 against hydrogen peroxide-induced oxidative stress in PC12 cell: the role of Nrf2 and antioxidant enzymes. Cell Mol Neurobiol 36:103\u2013111", "ArticleIdList": ["26072159", "10.1007/s10571-015-0224-4"]}, {"Citation": "Yen H-C, Li S-H, Majima HJ, Huang Y-H, Chen C-P, Liu C-C, Tu Y-C, Chen C-W (2011) Up-regulation of antioxidant enzymes and coenzyme Q10 in a human oral cancer cell line with acquired bleomycin resistance. Free Radical Res 45(6):707\u2013716", "ArticleIdList": ["10.3109/10715762.2011.572969"]}, {"Citation": "Mat\u00e9s JM, P\u00e9rez-G\u00f3mez C, De Castro IN (1999) Antioxidant enzymes and human diseases. Clin Biochem 32(8):595\u2013603", "ArticleIdList": ["10638941", "10.1016/S0009-9120(99)00075-2"]}, {"Citation": "Singh Z, Karthigesu IP, Singh P, Rupinder K: Use of malondialdehyde as a biomarker for assessing oxidative stress in different disease pathologies: a review. Iranian Journal of Public Health 2014, 43(Supple 3):7\u201316."}, {"Citation": "Jorat MV, Tabrizi R, Kolahdooz F, Akbari M, Salami M, Heydari ST, Asemi Z (2019) The effects of coenzyme Q10 supplementation on biomarkers of inflammation and oxidative stress in among coronary artery disease: a systematic review and meta-analysis of randomized controlled trials. Inflammopharmacology 27(2):233\u2013248", "ArticleIdList": ["30758695", "10.1007/s10787-019-00572-x"]}, {"Citation": "Farhangi MA, Alipour B, Jafarvand E, Khoshbaten M (2014) Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress. Arch Med Res 45(7):589\u2013595", "ArticleIdList": ["25450583", "10.1016/j.arcmed.2014.11.001"]}, {"Citation": "Abdollahzad H, Aghdashi MA, Jafarabadi MA, Alipour B (2015) Effects of coenzyme Q10 supplementation on inflammatory cytokines (TNF-\u03b1, IL-6) and oxidative stress in rheumatoid arthritis patients: a randomized controlled trial. Arch Med Res 46(7):527\u2013533", "ArticleIdList": ["26342738", "10.1016/j.arcmed.2015.08.006"]}, {"Citation": "Yen C-H, Chu Y-J, Lee B-J, Lin Y-C, Lin P-T (2018) Effect of liquid ubiquinol supplementation on glucose, lipids and antioxidant capacity in type 2 diabetes patients: a double-blind, randomised, placebo-controlled trial. Br J Nutr 120(1):57\u201363", "ArticleIdList": ["29936921", "10.1017/S0007114518001241"]}, {"Citation": "Dai Y-L, Luk T-H, Yiu K-H, Wang M, Yip PM, Lee SW, Li S-W, Tam S, Fong B, Lau C-P (2011) Reversal of mitochondrial dysfunction by coenzyme Q10 supplement improves endothelial function in patients with ischaemic left ventricular systolic dysfunction: a randomized controlled trial. Atherosclerosis 216(2):395\u2013401", "ArticleIdList": ["21388622", "10.1016/j.atherosclerosis.2011.02.013"]}, {"Citation": "Liu T, Zhang L, Joo D, Sun S-C (2017) NF-\u03baB signaling in inflammation. Signal Transduct Target Ther 2(1):1\u20139"}, {"Citation": "Fan L, Feng Y, Chen G-C, Qin L-Q (2017) Fu C-l, Chen L-H: Effects of coenzyme Q10 supplementation on inflammatory markers: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res 119:128\u2013136", "ArticleIdList": ["28179205", "10.1016/j.phrs.2017.01.032"]}, {"Citation": "Zhai J, Bo Y, Lu Y, Liu C, Zhang L (2017) Effects of coenzyme Q10 on markers of inflammation: a systematic review and meta-analysis. PLoS ONE 12(1):e0170172", "ArticleIdList": ["28125601", "5268485", "10.1371/journal.pone.0170172"]}, {"Citation": "Mazidi M, Kengne AP, Banach M (2018) Lipid, Group BPM-aC: Effects of coenzyme Q10 supplementation on plasma C-reactive protein concentrations: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res 128:130\u2013136", "ArticleIdList": ["28847708", "10.1016/j.phrs.2017.08.011"]}, {"Citation": "Al-Megrin WA, Soliman D, Kassab RB, Metwally DM, Moneim AEA, El-Khadragy MF (2020) Coenzyme Q10 activates the antioxidant machinery and inhibits the inflammatory and apoptotic cascades against lead acetate-induced renal injury in rats. Front Physiol 11:64", "ArticleIdList": ["32116774", "7020615", "10.3389/fphys.2020.00064"]}, {"Citation": "Liu Z, Li Y, Li C, Yu L, Chang Y, Qu M (2021) Delivery of coenzyme Q10 with mitochondria-targeted nanocarrier attenuates renal ischemia-reperfusion injury in mice. Mater Sci Eng, C 131:112536", "ArticleIdList": ["10.1016/j.msec.2021.112536"]}, {"Citation": "Yang Y-K, Wang L-P, Chen L, Yao X-P, Yang K-Q, Gao L-G, Zhou X-L (2015) Coenzyme Q10 treatment of cardiovascular disorders of ageing including heart failure, hypertension and endothelial dysfunction. Clin Chim Acta 450:83\u201389", "ArticleIdList": ["26254995", "10.1016/j.cca.2015.08.002"]}, {"Citation": "Xu Y, Li X, Zuo X, Jia H, Han E, Liang F, Xie L, Gao J (2020) Effects of coenzyme Q10 on endothelial and cardiac function in patients undergoing haemodialysis: study protocol for a pilot randomised controlled trial. BMJ Open 10(9):e036732", "ArticleIdList": ["32873669", "7467521", "10.1136/bmjopen-2019-036732"]}, {"Citation": "Gao L, Mao Q, Cao J, Wang Y, Zhou X, Fan L (2012) Effects of coenzyme Q10 on vascular endothelial function in humans: a meta-analysis of randomized controlled trials. Atherosclerosis 221(2):311\u2013316", "ArticleIdList": ["22088605", "10.1016/j.atherosclerosis.2011.10.027"]}, {"Citation": "Tsai K-L, Huang Y-H, Kao C-L, Yang D-M, Lee H-C, Chou H-Y, Chen Y-C, Chiou G-Y, Chen L-H, Yang Y-P (2012) A novel mechanism of coenzyme Q10 protects against human endothelial cells from oxidative stress-induced injury by modulating NO-related pathways. J Nutr Biochem 23(5):458\u2013468", "ArticleIdList": ["21684136", "10.1016/j.jnutbio.2011.01.011"]}, {"Citation": "Awad K, Sayed A, Banach M: Coenzyme Q10 reduces infarct size in animal models of myocardial ischemia-reperfusion injury: a meta-analysis and summary of underlying mechanisms. Frontiers in cardiovascular medicine 2022, 9."}, {"Citation": "Aslanabadi N, Safaie N, Asgharzadeh Y, Houshmand F, Ghaffari S, Garjani A, Dousti S, Hamishehkar H, Entezari-Maleki T (2016) The randomized clinical trial of coenzyme Q10 for the prevention of periprocedural myocardial injury following elective percutaneous coronary intervention. Cardiovasc Ther 34(4):254\u2013260", "ArticleIdList": ["27214383", "10.1111/1755-5922.12195"]}, {"Citation": "Sunamori M, Tanaka H, Maruyama T, Sultan I, Sakamoto T, Suzuki A (1991) Clinical experience of coenzyme Q10 to enhance intraoperative myocardial protection in coronary artery revascularization. Cardiovasc Drugs Ther 5(2):297\u2013300", "ArticleIdList": ["1854669", "10.1007/BF00054751"]}, {"Citation": "Hidaka T, Fujii K, Funahashi I, Fukutomi N, Hosoe K (2008) Safety assessment of coenzyme Q10 (CoQ10). BioFactors 32(1\u20134):199\u2013208", "ArticleIdList": ["19096117", "10.1002/biof.5520320124"]}, {"Citation": "Arenas-Jal M, Su\u00f1\u00e9-Negre J, Garc\u00eda-Montoya E (2020) Coenzyme Q10 supplementation: efficacy, safety, and formulation challenges. Comprehensive reviews in food science and food safety 19(2):574\u2013594", "ArticleIdList": ["33325173", "10.1111/1541-4337.12539"]}, {"Citation": "Baggio E, Gandini R, Plancher A, Passeri M, Carmosino G (1994) Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure. Mol Aspects Med 15:s287\u2013s294", "ArticleIdList": ["7752841", "10.1016/0098-2997(94)90040-X"]}, {"Citation": "Feigin A, Kieburtz K, Como P, Hickey C, Abwender D, Zimmerman C, Steinberg K, Shoulson I (1996) Assessment of coenzyme Q10 tolerability in Huntington\u2019s disease. Movement Disorders: Official Journal of the Movement Disorder Society 11(3):321\u2013323", "ArticleIdList": ["8723151", "10.1002/mds.870110317"]}, {"Citation": "Sood B, Keenaghan M: Coenzyme Q10. In: StatPearls [Internet]. edn.: StatPearls Publishing; 2022."}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "6", "Day": "14"}, {"Year": "2023", "Month": "7", "Day": "25"}, {"Year": "2023", "Month": "9", "Day": "18", "Hour": "12", "Minute": "42"}, {"Year": "2023", "Month": "8", "Day": "1", "Hour": "1", "Minute": "8"}, {"Year": "2023", "Month": "7", "Day": "31", "Hour": "23", "Minute": "29"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37524929", "10.1007/s00228-023-03546-9", "10.1007/s00228-023-03546-9"]}}], "PubmedBookArticle": []}